Evom­mune rais­es $115M for I&I pipeline and pre­pares for Phase 2 re­sults

An­oth­er in­flam­ma­tion and im­munol­o­gy start­up has at­tract­ed big bucks.

On Thurs­day, Evom­mune an­nounced a $115 mil­lion raise to back a pipeline an­tic­i­pat­ed to have mul­ti­ple …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER